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Background: Septic acute liver and intestinal failure is associated with a high mortality. We therefore investigated
the influence of volume resuscitation with different crystalloid or colloid solutions on liver and intestine injury and
microcirculation in septic rodents.
Methods: Sepsis was induced by cecal ligation and puncture (CLP) in 77 male rats. Animals were treated with
different crystalloids (NaCl 0.9% (NaCl), Ringer’s acetate (RA)) or colloids (Gelafundin 4% (Gel), 6% HES 130/0.4 (HES)).
After 24 h animals were re-anesthetized and intestinal (n = 6/group) and liver microcirculation (n = 6/group) were
obtained using intravital microscopy, as well as macrohemodynamic parameters were measured. Blood assays and
organs were harvested to determine organ function and injury.
Results: HES improved liver microcirculation, cardiac index and DO2-I, but significantly increased IL-1β, IL-6 and
TNF-α levels and resulted in a mortality rate of 33%. Gel infused animals revealed significant reduction of liver and
intestine microcirculation with severe side effects on coagulation (significantly increased PTT and INR, decreased
haemoglobin and platelet count). Furthermore Gel showed severe hypoglycemia, acidosis and significantly
increased ALT and IL-6 with a lethality of 29%. RA exhibited no derangements in liver microcirculation when
compared to sham and HES. RA showed no intestinal microcirculation disturbance compared to sham, but
significantly improved the number of intestinal capillaries with flow compared to HES. All RA treated animals
survided and showed no severe side effects on coagulation, liver, macrohemodynamic or metabolic state.
Conclusions: Gelatine 4% revealed devastated hepatic and intestinal microcirculation and severe side effects in CLP
induced septic rats, whereas the balanced crystalloid solution showed stabilization of macro- and
microhemodynamics with improved survival. HES improved liver microcirculation, but exhibited significantly
increased pro-inflammatory cytokine levels. Crystalloid infusion revealed best results in mortality and
microcirculation, when compared with colloid infusion.
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Figure 1 Experimental setup. All animals were randomized and
analysed in a blinded fashion. The aim was to analyse 6 animals
per group for intestinal and liver microcirculation. Since animals
died due to the initiated sepsis, additional animals were
randomized and analysed.
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Acute liver failure (ALF) and sepsis share some con-
formity, e.g. coagulopathy, shock and a high mortality.
As a combination of both, the sepsis induced ALF is the
lethal duo. Despite of intensive research and improve-
ment of treatment, patients in septic shock as well as
patients with ALF show a survival rate of less than
50% [1,2].
The liver and the intestine play a pivotal role in sepsis
by modulating immune response due to release and fil-
tering cytokines, bacterial fragments and vasomodulating
substances. Hepatic hypoperfusion and microcirculation
disturbances lead to contracted sinusoids, swollen sinus-
oidal endothelial cells and activated Kupffer cells. The
hepatic response to this stimulus is a release of toxic,
pro-inflammatory and vasoactive substances, which trig-
ger the vicious circle of multi organ failure (MOF) and
death [3,4]. The hepatic histopathological changes prom-
inent after septic shock may be due to impaired micro-
circulation and therefore cellular hypoxia [5]. Hepatic
perfusion is clinically difficult to determine and can’t be
predicted by systemic hemodynamic parameters. How-
ever cardiac output (CO) showed a direct correlation
to total hepatic flow [6] but hepatic microcirculation
remained heterogeneous with regional flow deficits.
During septic shock in pigs superior mesenteric artery
and hepatic microcirculation flow decreased about
50% and hydroxyethylstarch administration improved
splanchnic blood flow but not microvascular liver perfu-
sion [4]. In addition repeated administration of hydro-
xyethylstarch can aggravate portal hypertension, liver
failure and sepsis in patients with chronic liver disease
[7]. On the other side, Catre and colleagues have demon-
strated protective effects of HES 130/0.4 on hepatic
reperfusion damage [8]. However volume resuscitation is
a cornerstone in the treatment of sepsis and shock. The
volume replacement strategies are different between
countries and are even different between ICUs in the
same hospital [9]. Crystalloids (CL) and natural or artifi-
cial colloids (COL) are commonly used to restore fluid
balance.
In the last decades controversy results were published
and now the German sepsis guidelines 2010 recom-
mended the use of CL in sepsis. Despite of numerous
clinical studies there is no evidence for the safety use of
third generation HES 130/0.4 in critical ill patients [10].
In contrast there are increasing results of severe side
effects of synthetic colloids to kidney function and mor-
tality [11-14]. However little is known about the impact
of different CL and COL solutions on the hepatic and in-
testinal microcirculation in sepsis. Therefore we designed
this study to investigate the direct influence of different
solutions on liver and intestine microcirculation and
function in a rodent sepsis model.Methods
Animals
After animal care committee approval (Laboratory Ani-
mal Care and Use Committee of the District of Unter-
franken, Germany), which meets applicable European
legislation and the standards of the National Institutes
of Health as set forth in the Guide for the Care and
Use of Laboratory Animals (National Research Council,
Washington: National Academy Press, 1996), experi-
ments were performed on 80 male Sprague–Dawley rats
(345 ± 30 g bodyweight (BW), Harlan Winkelmann,
Germany). All animals were maintained on a standard
diet, water ad libitum and 12 h day and night cycles. Ani-
mals were not fasted prior and after the CLP procedure.
Experimental protocol
Animals were randomized (Figure 1) to receive liver or
intestine examination and afterwards to group (grp) I-V
(n = 6/ grp), grp I: Sham, grp II: NaCl (NaCl 0,9%
Fresenius Kabi, Germany), grpIII: RA (Ringer’s acetate,
SterofundinWISO B. Braun Melsungen AG, Germany),
grp IV: Gel (Gelafundin 4%, B. Braun Melsungen AG,
Germany), grp V: HES (6% HES 130/0,4, VoluvenW,
Fresenius Kabi, Germany), and anesthetized using isoflur-
ane(ForeneW, Abbott, Germany)/ nitrous oxide inhalation.
The carrier solution of Gel and HES consisted of aqua ad
injectabilis (Gel: sodium 154 mval, chloride 120 mval;
HES: sodium 154 mval, chloride 154 mval). Body tem-
perature was monitored via a rectal probe during surgery
and intravital microscopy. Body temperature was main-
tained at 37.0 ± 0.5°C with a heated plate and heating
lamps. For volume replacement and drug application the
right jugular vein and for continuous blood pressure
measurement, heart rate (Hewlett Packard Model 88S)
and gaining blood samples the left carotid artery were
canulated. The catheters were subcutaneously transferred
to the occiput and further on through a small incision
into a Swivel device (Instech, Plymouth, USA). This
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continuously hemodynamic measurements. Afterwards
median laparotomy was performed, the coecum was
mobilized and grp II-V underwent standardized CLP, as
had been described in detail previously by Singleton et. al
[15]. In brief, 25% of the coecum was ligated and punctu-
red twice using a sterile 18-gauge needle. Postoperatively,
all rats received fluid resuscitation as follows: Animals of
all groups received 0.5 ml/100 g BW/h NaCl as basal
fluid therapy. Additionally, all sepsis groups received
1.0 ml/100 g BW/h NaCl (grp II), RA (grp III), Gel
(grp IV) or HES (grp V) respectively (Figure 2). Analgesia
was continuously provided i.v. by the following protocol:
grp I: 0.25 μg/100 g BW/h fentanyl (Fagron, Germany);
grp II-VI: 2.0 μg/100 g BW/h fentanyl. All animals had
access to a standard diet and water ad libitum. After
24 hours rats were re-anaesthetized. A combined anaes-
thesia was used with A) Continuously i.v. medication: for
sedation: Midazolam (Midazolam-ratiopharmW, Ratio-
pharm, Germany) 0.7 mg/100 g BW/h, and for analgesia:
the opioid Fentanyl 7 μg/100 g BW/h and B), inhaled
anaesthetics for a sufficient anaesthetic depth using
isoflurane (0.6-0.8 Vol%). For a sufficient oxygenation
(SaO2 > 93% and PaO2 > 60 mmHg) a tracheotomy was
performed and rats were mechanically ventilated withFigure 2 Survival curves. Schematic presentation of the
experimental trial. Sepsis was performed by coecum ligation and
puncture (CLP). Central venous line (CVL) and continuous invasive
arterial pressure line (Art.) were implanted and fluid administration
was performed (group (Grp), body weight (BW)). Blood gas analyses
(BGA) were measured 30 minutes after surgical procedures and after
24 h with cardiac output (CO) calculations. Afterwards data of the
liver sinusoidal and intestinal blood flow were collected using
intravital microscopy (IVM) and at the end of the experiment blood
samples and organs (B&O) were harvested.FiO2 0.28 using a Rodent Ventilator (Type: 7025, Hugo
Sachs Elektronic KG, Germany). Tidal volume remained
the same for all animals, if necessary breathing frequency
was adjusted. For cardiac output (CO) measurements the
right femoral artery was canulated and a thermocatheter
(MLT1402 T-type Ultra Fast Thermocouple, ADInstru-
ments) was introduced. CO was measured by thermodi-
lution using 300 μl icecold NaCl and PowerLabW
(ADInstruments) software. Parameters were calculated
as described previously [16]. Blood gas values were
measured using ABL505 blood gas analyzer (Radiometer,
Copenhagen). After microcirculatory measurements or
sham operation animals were sacrificed in deep anaesthe-
sia by blood samples taken from the arterial line. Animals
which died before 24 h or had MAP levels < 70 mmHG
during the 24 h after CLP were excluded from the study.
Intravital microscopy
Liver-microcirculation
For the realization of the intravital microscopy of the left
liver lobe a transverse subcostal and median incision
was performed (n = 6 for each group). The hepatic liga-
ments of the left liver lob were dissected and rats were
placed in a 110° left position onto a modified inverted
Zeiss microscope (Axiovert 200, Carl Zeiss, Göttingen,
Germany). The edge of the left liver lobe was gently
taken out and spread on a specific pillar. The lower sur-
face was placed on a modified cover glass to perfuse the
liver lob with 37°C warm NaCl, and heat lamps pre-
served body temperature. Blood perfusion within indi-
vidual sinusoids was studied after contrast enhancement
by fluorescein isothiocyanate-albumin (5 μg/100 g intra-
venously Sigma, Deisenhofen, Germany) and fluorescein
sodium (1 μg/g intravenously Sigma, Deisenhofen,
Germany) slow i.v. administration. The liver surface was
epi-illuminated using a 100-W mercury lamp and a filter
set consisting of a 450- to 490-nm excitation and a
520-nm emission bandpass filter. Than observations of
the liver microcirculation were captured using different
lenses (Achroplan × 10 NA0.25/×20 NA0.4/×40 NA 0.6)
and digitally recorded for subsequent off-line analysis by
an investigator blinded to the treatment groups. The si-
nusoidal diameter was assessed at sites associated with
vitamin A autofluorescence linked to hepatic stellate cells
as described previously [17]. At least 10 fields of view/
animal were analyzed and a minimum of ten sinusoids
were analysed per field of view. Details of this technique
have been described elsewhere [18,19].
Intestinal microcirculation
In anesthetized animals, a median laparotomy was per-
formed for the investigation of intestinal microcirculation.
A part of the ileum was taken out and spread on a specific
pillar without any distortion. Thereafter a incision at the
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ent intestinal vessels) was done. One of the two halves
was put on the object plate of the microscope to measure
microcirculation. Suction tubes were inserted into the lu-
minal side of the ileum to drain off the feces. Afterwards
ileum tissue was kept wet and warm by 37°C NaCl-
Solution and heat lamps preserved body temperature
Microcirculation in at least eight villi was performed as
described above. Functional Capillary Density, Velocity
and Vessel-Diameter were measured after contrast en-
hancement by fluorescein isothiocyanate-albumin (7 μg/
100 g i.v.) administration with the same lamp and filter
as for the liver perfusion. For counting activated leuko-
cytes rhodamine 6 G (1.5 mg/100 g intravenously Sigma,
Deisenhofen, Germany) was administered. Then observa-
tions of the gut microcirculation were captured using dif-
ferent lenses [Achroplan × 20 NA 0.4 and × 40 NA 0.6
(leukocytes); 497 nm-excitation and a 524 nm-emission
filter).] and digitally recorded for subsequent off-line ana-
lysis by an investigator blinded to the treatment groups.
Evaluation of microcirculatory flow
Velocity of erythrocytes was measured by a blinded in-
vestigator using Software MetaMorph V 6.1r4. For each
point of time the velocities of 24 randomly chosen ery-
throcytes were measured for one image section and for
each animal 3 sections were performed. For sinusoidal
diameter 10 randomly chosen distances were measured
through out one section. From these data volumetric
flow was calculated based as described previously [20];
Volumetric blood flow (VQ) = (diameter [μm])2x(1/4xπ))
x erythrocyte velocity [μm/ms]). Functional capillary
density was measured by putting a grid across the region
of interest and perfused capillaries crossing the gridlines
were counted in a 30 s sequence. The value is described
as capillaries per μm gridline [21].
Macrohaemodynamic monitoring and evaluation
Mean arterial pressure (MAP) and heart rate were con-
tinuously measured. Cardiac index (CI), stroke volume
index (SVI), total peripheral resistance index (TPRI) and
delivery oxygen index (DO2-I) were calculated as recently
published using the following equations [16]: Cardiac
index (CI) [ml/min/kg] = cardiac output/BW; stroke vol-
ume index (SVI) [ml/beat/kg] = CI/heart rate; Total per-
ipheral resistance (TPRI) [mmHg/ml/min/kg] = MAP/CI;
delivery of oxygen index (DO2-I) = (CI x (((SaO2 [%]/100)
xHb [g/dl]x1,34) + SaO2[%]x0.0031)/100) while SaO2 =
arterial oxygen saturation [%] ; Hb = haemoglobin [g/dl].
Markers of liver function
After vital microscopy plasma samples were drawn for
determination of liver function by measuring aspartatetransaminase (AST), alanine transaminase (ALT), alkaline
phosphatase (ALP), total bilirubin (TBIL), gamma gluta-
myltranspeptidase (GGT), albumin, glucose, INR, PTT,
haemoglobin (Hb) and platelet count by using routine
laboratory methods.
Cytokines
Blood was drawn at the end of experiment, centrifuged
at 3400 g for 10 min and 4°C. Afterwards samples were
frozen at −80°C. For quantification a commercial available
solid phase sandwich immunoassay for simultaneously
quantifying multiple biomarkers with the LuminexW-
method (‘Rat 10-Plex’ Invitrogen, Karlsruhe, Germany)
was used according to the manufacturer’s recom-
mendations. Analyses were done in triplicate with a
LuminexW100 intrument (Luminex Corporation, Austin,
Texas, USA).
Heamoxygenase-1 (HO-1)
Liver HO-1 was analyzed in triplicate by using standar-
dized western blotting as previously described (HO-1
(Hsp32) assaydesigns, Lörrach, Germany) [22].
Statistical analysis
Values are expressed as mean ± standard error. Possible
differences were assessed using SPSS 19.0 statistical soft-
ware. Statistical significance was determined by analysis
of variance (multivariate ANOVA followed by post-hoc
Duncan test, or for nonparametric values Kurskal-Wallis
test following Mann–Whitney-U Test and Bonferroni
correction) or by Students t-test to determine differences
in mean between the groups. Statistical significance is
assumed for p < 0.05.
Results
Kaplan maier survival plot
Overall sepsis mortality rate was 22%, whereas all sham
operated animals survived with no signs of sepsis during
the experiment. All animals infused with the crystalloid
RA survive and NaCl (33%), HES (33%) and Gel (29%)
exhibited reduced survival rates (Figure 3). Septic ani-
mals displayed, with no differences between the groups,
clinical features of illness from about 1–2 h after CLP
procedure, including a decrease in activity, reduced
alertness, ruffled fur, and hunched posture. This clinical
status deteriorated continuously over time. Control ani-
mals appeared outwardly normal.
Microcirculation
Liver
Despite of the increased mortality in the colloid
groups, volumetric flow [μm3/ms] of 6% HES 130/0.4
(15.3 ± 5.6) was significantly improved compared to
Gel (10.4 ± 3.9) and NaCL (10.2 ± 6) (Figure 4A).
Figure 3 CONSORT flow diagram. Kaplan meier survival plot. Gel treated animals revealed highest mortality (29%) followed by HES (28%) and
NaCL (28%), whereas all RA and control rats survived.
Schick et al. BMC Gastroenterology 2012, 12:179 Page 5 of 11
http://www.biomedcentral.com/1471-230X/12/179However no significant difference between RA (12.5 ±
3.6) and HES was detectable. Sinusoidal diameters were
significantly reduced as a sign of inflammation in all sep-
tic animals (NaCl 7.5 ± 1.7; RA 7.7 ± 2; Gel 7.6 ± 2.3; HES
7.5 ± 2.4 [μm]) compared to sham (8.3 ± 1.5 [μm]). Capil-
lary density was significantly reduced in NaCl and Gel
treated animals, whereas HES and RA showed no differ-
ences compared to sham (Figure 4A’). But all sepsis
groups revealed more vessels with slow velocity as a
marker of impaired microcirculation (data not shown).
Intestine
Volumetric blood flow [μm3/ms] was significantly lower
in Gel (11.1 ± 6.1) than in all other groups (Sham (15.9 ±
7.2), NaCl (16.9 ± 9.3), RA (14.9 ± 8.0), HES(15.2 ± 5.0);
Figure 4B). The number [n] of capillaries with flow were
significantly increased in the RA group (12.6 ± 3.7)compared to NaCl (9.9 ± 3.5) and HES (9.6 ± 3.5);
Figure 4B’). Intestinal vessel diameters were only signifi-
cantly increased in HES animals (6.6 ± 2.3 [μm]) when
compared to all other groups NaCl (6.0 ± 1.7), RA (6.1 ±
2.1) and Gel (6.2 ± 2.1). The number of moving leuco-
cytes was significantly higher in the Gel group than in
HES and RA. The total number [n] of activated leuco-
cytes (sticking and rolling) was significantly higher in Gel
(4.4 ± 3.2) compared to RA (2.5 ± 2.0) and HES (2.4 ± 1.9)
(data not shown).
Macrohemodynamics and blood gas analyses
MAP, CVP, HR, pH and paCO2, showed no significant
differences between the groups over time. CI [ml/min/kg]
was significantly increased in the colloid groups (HES
541 ± 60; Gel 481 ± 113) when compared with CL treated
animals. But SVI [ml/beat/min] did not significantly
Figure 4 Microcirculation. Liver microcirculation 24 h after CLP. NaCl and Gel revealed significantly decreased volumetric flow (A) and a
reduced amount of liver capillaries with flow (A’) compared to HES. A)Intesinal microcirculation 24 h after CLP. Gel treated animals showed
significant impairment of volumetric flow compared with all other groups (B). The number of perfused capillaries was significantly increased in
RA treated animals when compared with NaCl and HES (B’). n = 6 animal/ group; p < 0.05, mean ± SD; * vs. HES, § vs NaCl and RA, $ vs. RA.
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showed no differences between the groups, where as
DO2-I improved significantly in HES infused animals
compared to all other septic groups (Tables 1 & 2).
TPRI [mmHg/ml/min/kg] was reduced only in HES
(0.17 ± 0.1) infused animals. Hb [g/dl] was significantly
reduced in Gel (8.7 ± 1.3) and HES group (11.4 ± 1.4)
when compared to sham (13.9 ± 0.8; Table 1). NaCl
and Gel group revealed metabolic acidosis represented
as significantly reduced pH, HCO3
- , SBE (Table 2). All
other septic animals demonstrated also derangements
in metabolic state but reached no significance due to
elevated standard deviation.Table 1 Evaluation of macrohemodynamic parameters after m
Groups paO2 SaO2 Hb CI HR
[mmHG] [%] [g/dl] [ml/min/kg] [/min]
Sham 124 ± 28 96 ± 2 13.9 ± 0.8 355 ± 60 411 ± 48
NaCL 119 ± 44 95 ± 2 12.6 ± 1.7 332 ± 162 405 ± 40
RA 94 ± 42 90 ± 9 12.4 ± 1.9 374 ± 150 439 ± 40
Gel 115 ± 42 92 ± 9 8.7 ± 1.3* 481 ± 113* 437 ± 55
HES 119 ± 43 96 ± 2 11.4 ± 1.4* 582 ± 85#* 429 ± 37
(cardiac index (CI), stroke volume index (SVI), delivery oxygen index (DO2-I), total peCytokines
IL-1b, IL 10 and TNFα showed significantly elevated
levels in the HES group when compared with crystal-
loids. IL-6 levels were significantly higher in the Gel-
and HES-group (Figure 5).Liver injury and function
Injury markers The biomarkers for liver injury AST, AP
as well as HO-1 did not show any difference between all
groups, but AST tended to be increased in all septic ani-
mals and Gel showed the highest level. ALT [U/l] wasechanical ventilation and 24 h CLP or sham
SVI MAP DO2-I TPRI
[ml/beat/min] [mmHG] [ml/min/kg] [mmHg/ml/min/kg]
0.87 ± 0.13 101 ± 22 64,6 ± 11 0.29 ± 0.06
1,04 ± 0.39 91 ± 23 69,7 ± 38 0.23 ± 0.10
0.85 ± 0.33 98 ± 18 54,4 ± 18.8 0.29 ± 0.12
1.1 ± 0.24 91 ± 17 52,6 ± 13.9 0.20 ± 0.07
1.36 ± 0.21* 96 ± 20 88,6 ± 21* 0.17 ± 0.10*
ripheral resistance index (TPRI); p < 0.05, *vs sham,# vs RA and NaCl.
Table 2 Blood gas analyses measured 30 min after surgical procedures (baseline) and after intravital microscopy
Baseline pH paCO2
[mmHG]
HCO3−[mmol/l] SBE−[mmol/l] 24 h CLP pH paCO2
[mmHG]
HCO3− [mmol/l] SBE−[mmol/l]
Sham 7,47 ± 0,05 38 ± 6 27,1 ± 1,5 3,5 ± 1,6 Sham 7,40 ± 0,03 39 ± 7 23,7 ± 3,8 −0,2 ± 3,4
NaCl 7,4 ± 0,02 44 ± 4 26,7 ± 2,0 2,3 ± 2,0 NaCl 7,29 ± 0,15 37 ± 10 20,2 ± 4,2* −6,5 ± 4,8
RA 7,44 ± 0,02 41 ± 3 28,7 ± 4,6 3,4 ± 1,0 SteroIso 7,37 ± 0,05 41 ± 6 24,7 ± 3,8 −1,4 ± 3,5
Gel 7,42 ± 0,04 39 ± 6 25,6 ± 2,5 1,1 ± 2,7 Gel 7,26 ± 0,11* 33 ± 12 15,1 ± 5,9* −10,7 ± 6,7*$
HES 7,41 ± 0,04 45 ± 6 27,9 ± 4,1 2,8 ± 1,7 HES 7,37 ± 0,03 37 ± 3 21,3 ± 2,2 −4,6 ± 5,7
p < 0.015-0.05, * vs. sham;$ vs. RA.
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(168 ± 117) group compared to sham (55 ± 12, Table 3).
Liver function
The investigation of liver function revealed a significant
reduction of albumin in all septic rats and gelatine trea-
ted animals showed the lowest albumin levels com-
pared with all other investigated groups. Colloids showed
increased lactate levels whereas Gel treated animals
revealed the highest levels. Gel [mg/dl] infused animals
had significantly decreased glucose level (33 ± 44) com-
pared with NaCl (121 ± 33), RA (124 ± 33) and HES
(126 ± 50), (Figure 6).
Coagulation disorders
Gelatine infusion led to significant coagulation impair-
ments. INR (1.51 ± 0.5) and PTT (108 ± 40) wereFigure 5 Cytokines. Box-and-whisker plots showing cytokine levels of the
cytokines when compared with other septic animals. The boxes represent
represent median values. The whiskers represent the lowest and highest va
regions; n = 10-12 per group; p < 0.05; * vs. sham, & vs. Gel, RA and NaCl, #significantly increased compared to all other groups.
Platelet counts [*1000/μl] were significantly decreased in
the colloid groups Gel (56 ± 50) and HES (83 ± 71) when
compared with crystalloids (Figure 7).
Discussion
Volume resuscitation is a pivotal therapy in sepsis and
septic shock, but the level of evidence-based recommen-
dation of the type of intravenous fluid is still low. Fur-
thermore the required quantity of volume to stabilize
haemodynamics remains a challenge by the complex
interaction of endothelial-, epithelial barrier disruption,
cytokine storm, septic cardiomyopathy, hypo- or hyper-
thermia, cavity edema, coagulation disorders with con-
secutive bleeding and co-morbidity [23].
In patients suffering from endothelial barrier disrup-
tion like in sepsis, the estimated volume effect of colloidsserum 24 h after CLP. HES animals showed increased levels of
the 25th to 75th percentiles, and horizontal lines within the box
lue in the 25th percentile minus 1.5IQR and 75th percentile plus 1.5IQR
vs. RA and NaCl.
Table 3 Liver parameters measured at the end of
experiment
Group AP AST ALT GGT
(U/l) (U/l) (U/l) (U/l)
Sham 128 ± 43 162 ± 64 55 ± 12 1,9 ± 2,1
NaCl 117 ± 41 258 ± 207 168 ± 117* 3,5 ± 2,5
SteroIso 151 ± 58 249 ± 81 105 ± 41 5,8 ± 3,5
Gel 147 ± 51 427 ± 361 341 ± 423* 5,1 ± 3,4
HES 163 ± 72 297 ± 246 142 ± 48 5,8 ± 5,1
p < 0.05, mean ± SD, *vs sham.
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Starch for Severe Sepsis/Septic Shock (6S) trial, patients
in the HES group received almost the same amount of
volume when compared with patients in the RA group
to achieve hemodynamic stabilisation [13]. Silva et al.
have shown recently in rats with CLP-induced sepsis
that an infusion of 6 ml/100gBW/h with gelatine
resulted in hypervolemia [21]. The right colloid to crys-
talloid ratio is still an open question, and we therefore
decided to use a 1:1 ratio to investigate the same amount
of different infusion solutions. Furthermore our fluid re-
gime comprises two sections: 1) 0.5 ml/100gBW/h NaCl:
to cover the normal fluid intake of rats and 2) additional
we administered 1.0 ml/100gBW/h of the different solu-
tions to compensate fluid loss of surgical procedures and
sepsis (Figure 2). Singelton et al. showed a 40% mortality
rate in the first 24 h and a significant elevated IL-6 level,
when 25% of the coecum was ligated and punctured
twice [15]. We established this model in our lab to
achieve severe sepsis and a reduction of lethality by suf-
ficient analgesia and volume resuscitation. The aim of
the protocol was to get a fast (within 24 h) onset of
beneficial and/or adverse side effects of fluid solutions in
septic rats, and not a “patient” adapted goal directed
fluid resuscitation trial. The degradation of starchFigure 6 Liver function. Box-and-whisker plots showing functional liver p
level was significantly reduced compared to all other groups. Albumin was
compared to all other groups. Kolloids showed significant increased lactate
at the end of the experiment. The boxes represent the 25th to 75th percenti
whiskers represent the lowest and highest value in the 25th percentile minu
RA and HES; p < 0.05. n = 10-12 per group.molecules or the metabolic state of rats are two of nu-
merous differences between rodents and humans and
conclusions from animal models to clinical practice
should be done with caution. Most notably, our rodent
model, investigating 24 hours after the CLP procedure,
reflects the early stage of severe sepsis. Patients in the
clinical setting are often treated in the later phases of
severe sepsis.
However, the pathomechanism of septic liver failure is
poorly understood and it is meanwhile known, that
macrohemodynamic parameters do not reflect microcir-
culation and microcirculation by itself differs extensively
between different organs, even when systemic macrohe-
modynamic steady state values were achieved. Little is
known about the impact of different fluid solutions on
different intestinal organs, and there is still an ongoing
discussion about the ideal fluid solution in sepsis. The
scepticism about the benefit of synthetic colloids in
volume therapy is increasing [10,12,24]. Colloid solu-
tions should have a greater volume effect than crys-
talloids. Indeed, the colloid group had a significantly
increased cardiac index, but only the HES solution
resulted in an increased stroke volume index (Table 1).
Despite of significantly reduced Hb levels, HES showed
improved oxygen delivery, but other macrohemodynamic
parameters, such as HR, MAP and CVP, did not show
any differences between the septic groups (Table 1).
Furthermore HES infused rats had a decreased periph-
eral resistance, and in line only HES showed dilatation
of the intestine vessels. Additional HES improved volu-
metric flow of the liver sinusoids compared to Gel,
NaCL and HES had no decreased microcirculation and
number of capillaries under flow (CUF) in the liver
compared to sham (Figure 4). Interestingly only gel-
atine revealed impaired gut microcirculation, whereas
HES showed no such effect. RA revealed increased
number of CUF and did not impair volumetric flow ofarameters revealed severe side effects of gelatine infusion. Glucose
decreased in all septic animals, but Gel showed the lowest level
levels and Gel revealed the highest level. Parameters were determined
les, and horizontal lines within the box represent median values. The
s 1.5IQR and 75th percentile plus 1.5IQR regions; * vs. sham; § vs. NaCl,
Figure 7 Coagulation parameters. Box-and-whisker plots showing coagulation analyses 24 h after CLP. Gelatine infused rats showed
coagulation derangements. (The boxes represent the 25th to 75th percentiles, and horizontal lines within the box represent median values. The
whiskers represent the lowest and highest value in the 25th percentile minus 1.5IQR and 75th percentile plus 1.5IQR regions; p < 0.05; * vs. sham;
§ vs. NaCl, RA and HES; n = 10-12.
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microcirculation in the septic groups underline, that
different organ react differently to sepsis and volume
resuscitation. Taken together, 6% HES 130/0.4 revealed
a higher volume effect, increased DO2-I and showed
improvement of liver microcirculation and RA might
be benefical for the gut and liver microcirculation. But
the improvements in the starch group did not correl-
ate with survival. All septic animals showed the clinical
signs of severe sepsis and revealed an overall mortality
rate of 22%. HES, Gel and NaCL infused animals revealed
mortality around 30%, whereas the RA group survived
entirely. We have shown previously, that HES and Gel
impair kidney function in rodent sepsis [12]. COL solu-
tions resulted in functional and histological impairments
when compared with CL solutions. However, the effects
of the different solutions on the kidney may be causative
for the mortality differences between the groups.
RA was the only balanced solution in this trial, but
clinical data about the influence of balanced solutions
on mortality of patients remains heterogeneous. It has
been stated recently by Guidet et al., that balanced crys-
talloid solutions do not show any effect on mortality of
patients when compared with isotonic saline [25]. In our
study, animals treated with NaCl and Gel showed severe
acidosis. HES treated animals, with NaCl as a part of the
HES solution and saline as baseline infusion showed no
deranged acid base status. However the acid–base equi-
librium or the presence of a dilutional-hyperchloraemic
acidosis was not the focus of this survey.
Gelatine, which is often described as safe and harm-
less, developed acidosis, which may be due to reduced
Hb following anaerobic metabolism, and additionally Gel
group showed severe hypoglycaemia which may increase
lactate and aggravated metabolic acidosis. The acidosis
may be the reason for the coagulopathy, but NaCl trea-
ted animal revealed also reduced pH-level and had no
derangements in the coagulation parameters. However,Gelatine significantly impaired coagulation, represented
by elevated PTT, INR, decreased platelet count, as well
as clinical signs of coagulopathy (hematothorax, intraab-
dominal bleeding). This may be caused by a direct ef-
fect of gelatine on the coagulation system and on the
liver coagulation factor synthesis. It is well known that
artificial plasma expanders may influence the coagula-
tion system more than crystalloids in-vitro and in-vivo
beyond the effect of dilution [26]. In addition, colloids
could be stored by the reticulo endothelial system (RES)
and may lead to impaired phagocytic activity particularly
in septic shock [27]. Reduced phagocytic properties of the
RES lead to decreased elimination of activated fibronectin,
which can be stimulated by collagenous structures such as
gelatine. Thus the reduction of elimination might be an-
other explanation for the activated coagulation system by
gelatine in septic rats, which may lead to dissiminated
intravascular coagulopathy.
Vlahos et al. demonstrated that CLP impaired hepato-
cytes exocrine synthesis, and incubation with colloids
(albumin or HES) had a direct and dose depended impact
on albumin and urea production [28]. Furthermore CLP
pre-treated hepatocytes developed severe morphological
cell injury due to colloids despite metabolic activity
in vitro. Thus significantly increased level of ALT and
elevated AST in Gel group may be explained by acute
liver damage. However, despite of decreased microcircu-
lation, decreased sinusoidal diameter and impaired liver
function histopathology investigation did not show any
differences between the groups. This may due to the
short investigation period of 24 h. In opposite to syn-
thetical colloids RA showed no coagulopathy or liver
derangements.
It has been shown in the literature, that HES exhibits
an anti-inflammatory effect in different organs and spe-
cies. The main differences with our experiment are the
amount and incubation time of HES. Lv et al.showed an
anti-inflammatory response of HES compared to CL, but
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100gBW HES within one hour infusion regime in rats
[29]. Thus the CL group might be hyperinfused and the
consecutive hypervolemia increased cytokine levels itself.
However, this infusion strategy (COL to CL ratio of 1:4)
was the golden standard. We could show, that 24 h high
colloid exposition lead to a significant increase of pro-
inflammatory cytokines such as TNF-α, IL-1β and IL-6
in HES group.
Conclusion
The balanced crystalloid infusion RA could stabilize
micro- and macrohemodynamic, had least side effects
and all animals survived when used in septic rats. 6%
HES 130/0.4 improved cardiac output, DO2-I and micro-
circulation of the liver, but showed elevated IL-1β, IL-6
and TNF-α levels and a mortality rate of 33%. Gelatine
4% revealed severe coagulopathy, hypoglycaemia, ele-
vated liver enzymes, impaired microcirculation and a
29% lethality. Taken together, in our rodent model of
CLP-induced severe sepsis, crystalloid infusion revealed
best results in mortality and microcirculation when
compared with colloid infusion.
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